Connectome Health Raises $2 Million in Pre-Seed Round
Connectome Health, a Zurich-based company specializing in cognitive intelligence, has successfully raised $2 million in a pre-seed funding round. This latest round was led by Redstone, with additional participation from Concept Ventures, Octopus, and Transatlantic Angels. The funding, announced on April 1, 2026, aims to enhance Connectome Health's platform, which is designed to measure and understand brain changes over time using reliable, science-backed data.
About the Company
Connectome Health is focused on developing technology that provides transparent insights into how the brain evolves. This platform is intended to be a trustworthy resource for both individuals and organizations seeking to understand cognitive changes.
Rufus Mitchell-Heggs, a co-founder of Connectome Health, plays a pivotal role in steering the company's mission to deliver cutting-edge cognitive intelligence solutions.
Use of Funds
The $2 million infusion will primarily be used to further develop Connectome Health's platform capabilities. While specific plans for the use of funds were not disclosed, such investments typically aim at enhancing technical infrastructure, expanding research capabilities, or increasing the team size to accelerate product development.
Investors Behind the Round
Redstone led the funding round, showing confidence in Connectome Health's innovative approach to cognitive intelligence. Other investors, including Concept Ventures, Octopus, and Transatlantic Angels, also participated, indicating broad interest in the company's potential to impact the neurotechnology space.
Conclusion
With the backing from these prominent investors, Connectome Health is well-positioned to advance its platform and make significant strides in understanding cognitive changes. The fresh capital will enable the company to continue its work in providing valuable insights into brain health, contributing to the growing field of neurotechnology.